This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Which New 52 Week Highs You Should Buy Now

In the last month, the stock soared another 10% higher. When it comes to Walgreens, two thoughts come to mind. The first and most important for long term investors is Walgreens is the market leader, and they have pharmacy down to a science. Everyone else is playing catch up. If you're a "road warrior" (travel a lot for business) and regularly take medications, Walgreens is almost mandatory. There is no easier way to get a refill than to use Walgreens in case of lost/empty meds.

The second thought is for those seeking an ideal entry or shorter term investors. Walgreens isn't overbought, so I would not short it, but has a likely chance to retrace some of the recent gains. For the conservative investor, look for a price in the $36 to $36.50 range for entry.

After you enter or increase your position, start enjoying the large 3%-plus yield. The yield will not only improve your portfolio prognosis, but the low payout ratio is the cure.

Presently, based on the float the short interest is unimportant and not a worry. The small amount of short interest is 2.4%.

WAG Revenue Per Share TTM Chart WAG Revenue Per Share TTM data by YCharts

C Chart C data by YCharts

Citigroup (C - Get Report)

Citigroup, the leading global financial services company, has some 200 million customer accounts and does business in more than 100 countries. Citigroup trades an average of 39.2 million shares per day with a market cap of $115 billion.

52 Week High: $38.72

Beta: 1.58

Price to Book: 0.59

4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
WAG $81.65 2.05%
NRF $18.09 0.00%
BK $39.75 0.00%
BAC $15.31 0.00%
CCL $47.12 0.00%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs